ST002318 Mass spectroscopy‑based proteomics and metabolomics analysis of triple‑positive breast cancer cells treated with trastuzumab | ||||
Limit by pathway class: |
ST002318 Mass spectroscopy‑based proteomics and metabolomics analysis of triple‑positive breast cancer cells treated with trastuzumab | ||||
Limit by pathway class: |